These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 38825189)

  • 1. Applications, challenges, and prospects of induced pluripotent stem cells for vascular disease.
    Biswas PK; Park J
    Mol Cells; 2024 Jul; 47(7):100077. PubMed ID: 38825189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular diseases await translation of blood vessels engineered from stem cells.
    Samuel R; Duda DG; Fukumura D; Jain RK
    Sci Transl Med; 2015 Oct; 7(309):309rv6. PubMed ID: 26468328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Updated perspectives on vascular cell specification and pluripotent stem cell-derived vascular organoids for studying vasculopathies.
    Liu C; Niu K; Xiao Q
    Cardiovasc Res; 2022 Jan; 118(1):97-114. PubMed ID: 33135070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complex Organ Construction from Human Pluripotent Stem Cells for Biological Research and Disease Modeling with New Emerging Techniques.
    Matsumoto R; Yamamoto T; Takahashi Y
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous endothelialized small-caliber vascular grafts engineered from blood-derived induced pluripotent stem cells.
    Generali M; Casanova EA; Kehl D; Wanner D; Hoerstrup SP; Cinelli P; Weber B
    Acta Biomater; 2019 Oct; 97():333-343. PubMed ID: 31344511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced elastin synthesis and maturation in human vascular smooth muscle tissue derived from induced-pluripotent stem cells.
    Eoh JH; Shen N; Burke JA; Hinderer S; Xia Z; Schenke-Layland K; Gerecht S
    Acta Biomater; 2017 Apr; 52():49-59. PubMed ID: 28163239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem cell-derived vasculature: A potent and multidimensional technology for basic research, disease modeling, and tissue engineering.
    Lowenthal J; Gerecht S
    Biochem Biophys Res Commun; 2016 May; 473(3):733-42. PubMed ID: 26427871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac Organoids: A 3D Technology for Modeling Heart Development and Disease.
    Zhu L; Liu K; Feng Q; Liao Y
    Stem Cell Rev Rep; 2022 Dec; 18(8):2593-2605. PubMed ID: 35525908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineered 3D vessel-on-chip using hiPSC-derived endothelial- and vascular smooth muscle cells.
    Vila Cuenca M; Cochrane A; van den Hil FE; de Vries AAF; Lesnik Oberstein SAJ; Mummery CL; Orlova VV
    Stem Cell Reports; 2021 Sep; 16(9):2159-2168. PubMed ID: 34478648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges and opportunities for the next generation of cardiovascular tissue engineering.
    Cho S; Discher DE; Leong KW; Vunjak-Novakovic G; Wu JC
    Nat Methods; 2022 Sep; 19(9):1064-1071. PubMed ID: 36064773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering Brain-Specific Pericytes from Human Pluripotent Stem Cells.
    Jeske R; Albo J; Marzano M; Bejoy J; Li Y
    Tissue Eng Part B Rev; 2020 Aug; 26(4):367-382. PubMed ID: 32571167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implantable tissue-engineered blood vessels from human induced pluripotent stem cells.
    Gui L; Dash BC; Luo J; Qin L; Zhao L; Yamamoto K; Hashimoto T; Wu H; Dardik A; Tellides G; Niklason LE; Qyang Y
    Biomaterials; 2016 Sep; 102():120-9. PubMed ID: 27336184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced in vitro models of vascular biology: Human induced pluripotent stem cells and organ-on-chip technology.
    Cochrane A; Albers HJ; Passier R; Mummery CL; van den Berg A; Orlova VV; van der Meer AD
    Adv Drug Deliv Rev; 2019 Feb; 140():68-77. PubMed ID: 29944904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-specific cardiovascular progenitor cells derived from integration-free induced pluripotent stem cells for vascular tissue regeneration.
    Hu J; Wang Y; Jiao J; Liu Z; Zhao C; Zhou Z; Zhang Z; Forde K; Wang L; Wang J; Baylink DJ; Zhang XB; Gao S; Yang B; Chen YE; Ma PX
    Biomaterials; 2015 Dec; 73():51-9. PubMed ID: 26398309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of Human Induced Pluripotent Stem Cells in Generating Tissue-Engineered Blood Vessels as Vascular Grafts.
    Cong X; Zhang SM; Batty L; Luo J
    Stem Cells Dev; 2019 Dec; 28(24):1581-1594. PubMed ID: 31663439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue Engineering Using Vascular Organoids From Human Pluripotent Stem Cell Derived Mural Cell Phenotypes.
    Markou M; Kouroupis D; Badounas F; Katsouras A; Kyrkou A; Fotsis T; Murphy C; Bagli E
    Front Bioeng Biotechnol; 2020; 8():278. PubMed ID: 32363181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidney Disease Modeling with Organoids and Organs-on-Chips.
    Musah S; Bhattacharya R; Himmelfarb J
    Annu Rev Biomed Eng; 2024 Jul; 26(1):383-414. PubMed ID: 38424088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular organoids: unveiling advantages, applications, challenges, and disease modelling strategies.
    Naderi-Meshkin H; Cornelius VA; Eleftheriadou M; Potel KN; Setyaningsih WAW; Margariti A
    Stem Cell Res Ther; 2023 Oct; 14(1):292. PubMed ID: 37817281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of blood vessel organoids from human pluripotent stem cells.
    Wimmer RA; Leopoldi A; Aichinger M; Kerjaschki D; Penninger JM
    Nat Protoc; 2019 Nov; 14(11):3082-3100. PubMed ID: 31554955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human iPSC-Based Modeling of Central Nerve System Disorders for Drug Discovery.
    Qian L; Tcw J
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33530458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.